Literature DB >> 26366829

Clinical characteristics of pulmonary embolism with concomitant pneumonia.

Seung-Ick Cha1, Keum-Ju Choi, Kyung-Min Shin, Jae-Kwang Lim, Seung-Soo Yoo, Jaehee Lee, Shin-Yup Lee, Chang-Ho Kim, Jae-Yong Park.   

Abstract

Although pneumonia is associated with an increased risk of venous thromboembolism, patients with pulmonary embolism and concomitant pneumonia are uncommon. The aim of the present study was to investigate the clinical features of pulmonary embolism with coexisting pneumonia. We retrospectively compared clinical, radiologic and laboratory parameters between patients with pulmonary embolism and concomitant pneumonia (pneumonia group) and those with unprovoked pulmonary embolism (unprovoked group), and then between the pneumonia group and those with pulmonary infarction (infarction group). Of 794 patients with pulmonary embolism, 36 (5%) had coexisting pneumonia and six (1%) had no provoking factor other than pneumonia. Stroke was significantly more common in the pneumonia group, than either the unprovoked group or the infarction group. In the pneumonia group, fever was significantly more common and serum C-reactive protein levels were significantly higher. By contrast, central pulmonary embolism and right ventricular dilation on computed tomography were significantly less frequent in the pneumonia group. In addition, an adverse outcome due to pulmonary embolism was less common in the pneumonia group than in either of the other two groups. The coexistence of pulmonary embolism and pneumonia is rarely encountered in clinical practice, especially without the presence of other factors that could provoke venous thromboembolism and is commonly associated with stroke. It is characterized by lower incidences of central pulmonary embolism and right ventricular dilation and by a lower rate of adverse outcomes due to pulmonary embolism itself.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26366829     DOI: 10.1097/MBC.0000000000000411

Source DB:  PubMed          Journal:  Blood Coagul Fibrinolysis        ISSN: 0957-5235            Impact factor:   1.276


  5 in total

1.  Clinical symptoms and related risk factors in pulmonary embolism patients and cluster analysis based on these symptoms.

Authors:  Qiao-Ying Ji; Mao-Feng Wang; Cai-Min Su; Qiong-Fang Yang; Lan-Fang Feng; Lan-Yan Zhao; Shuang-Yan Fang; Fen-Hua Zhao; Wei-Min Li
Journal:  Sci Rep       Date:  2017-11-02       Impact factor: 4.379

2.  Anatomic and clinical risk factors for pulmonary embolism in patients with deep venous thrombosis of the lower extremity.

Authors:  Bomina Paik; Jin Hyun Joh; Ho-Chul Park
Journal:  Ann Surg Treat Res       Date:  2017-04-27       Impact factor: 1.859

3.  [Pulmonary embolism during SARS-CoV-2 pandemic: clinical and radiological features].

Authors:  A García-Lledó; M Del Palacio-Salgado; C Álvarez-Sanz; M M Pérez-Gil; Á Cruz-Díaz
Journal:  Rev Clin Esp       Date:  2021-01-16       Impact factor: 3.064

4.  Construction of a Risk Prediction Model for Hospital-Acquired Pulmonary Embolism in Hospitalized Patients.

Authors:  Lengchen Hou; Longjun Hu; Wenxue Gao; Wenbo Sheng; Zedong Hao; Yiwei Chen; Jiyu Li
Journal:  Clin Appl Thromb Hemost       Date:  2021 Jan-Dec       Impact factor: 2.389

5.  Development and validation of a novel risk assessment model to estimate the probability of pulmonary embolism in postoperative patients.

Authors:  Mao-Feng Wang; Fei-Xiang Li; Lan-Fang Feng; Chao-Nan Zhu; Shuang-Yan Fang; Cai-Min Su; Qiong-Fang Yang; Qiao-Ying Ji; Wei-Min Li
Journal:  Sci Rep       Date:  2021-09-10       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.